Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-10-01 18:32:36 - browse：6

Alnylam headquarters — Kristoffer Tripplaar/Sipa USA/AP

Alnylam Pharmaceuticals said Thursday that sales of its treatments for rare diseases grew 43% in the second quarter compared to the year-ago period, as the biotech prepares for a key meeting with the Food and Drug Administration in September.

Net product sales in the quarter were $306 million, led by Amvuttra, the company’s RNAi treatment for hereditary ATTR, with sales of $132 million, exceeding Wall Street forecasts. Sales of Onpattro, its older medicine for hereditary ATTR, were $91 million, slightly less than expectations.

The FDA has scheduled a meeting of outside experts on Sept. 13 to discuss the company’s application to expand the indication for Onpattro to include ATTR-CM, a related condition that affects the heart. The FDA decision is due by Oct. 8. An expansion would open a much larger market for the drug than its current approval, which largely targets nerve-related damage.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Former medical device CEO who sold dummy, plastic parts convicted of fraud

hotspot

WSS

Amylyx ALS drug fails large clinical trial

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

The Readout: Amylyx, Alumis, and Lundbeck drug updates

Telehealth startups are trying to fill the menopause care vacuum

The drug industry has found itself all alone in Washington

Stanford president’s abrupt resignation sparks debate

focus

Wikipedia

focus

Cancer drug shortages should be causing more outrage

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Guidelines to prevent youth baseball injuries need more muscle

A new ‘biological computer' targets cancer while sparing healthy cells

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Stanford president’s abrupt resignation sparks debate

23andMe had bad news about my health. I wish a person had delivered it

A deep dive into Applied Therapeutics’ data, and questions on Cassava

In Memoriam: Notable people who died in 2023

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Wikipedia

After a decade, new Gardasil ad campaign gets it (mostly) right

Telehealth startups are trying to fill the menopause care vacuum

Headspace, Meta partner to launch VR meditation app for Quest

Stanford president’s abrupt resignation sparks debate

Headspace, Meta partner to launch VR meditation app for Quest

Amylyx ALS drug fails large clinical trial

hotspot

Wikipedia

hotspot

Wikipedia